Diffuse large B cell lymphoma: How can we cure more patients in 2012? Journal Article
| Author: | Moskowitz, C. |
| Article Title: | Diffuse large B cell lymphoma: How can we cure more patients in 2012? |
| Abstract: | Clinically this chapter will focus on 3 important issues critical in the management of diffuse large B cell lymphoma (DLBCL) in 2012: risk stratification, interim PET-CT scanning and the role of high dose therapy and ASCT in the rituximab era for patients with relapsed and primary refractory disease. © 2012 Elsevier Ltd. All rights reserved. |
| Keywords: | immunohistochemistry; disease-free survival; review; cisplatin; doxorubicin; cancer risk; cytarabine; rituximab; drug megadose; positron emission tomography; ki 67 antigen; carboplatin; protein bcl 2; computer assisted tomography; gene expression profiling; etoposide; antineoplastic combined chemotherapy protocols; neoplasm proteins; tumor markers, biological; recurrence; cyclophosphamide; dexamethasone; vincristine; autologous stem cell transplantation; drug resistance, neoplasm; risk factor; ifosfamide; risk assessment; gene expression regulation, neoplastic; hla dr antigen; fdg-pet; cancer relapse; large cell lymphoma; lymphoma, large b-cell, diffuse; cd5 antigen; phase 3 clinical trial (topic); diffuse large b cell lymphoma; antibodies, monoclonal, murine-derived; positron-emission tomography and computed tomography; cell or origin; double hit lymphoma |
| Journal Title: | Best Practice and Research: Clinical Haematology |
| Volume: | 25 |
| Issue: | 1 |
| ISSN: | 1521-6926 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2012-03-01 |
| Start Page: | 41 |
| End Page: | 47 |
| Language: | English |
| DOI: | 10.1016/j.beha.2012.01.008 |
| PROVIDER: | scopus |
| PUBMED: | 22409822 |
| DOI/URL: | |
| Notes: | --- - "Export Date: 2 April 2012" - "CODEN: BPRCA" - "Source: Scopus" |
